160 related articles for article (PubMed ID: 11164803)
1. Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
Parain K; Marchand V; Dumery B; Hirsch E
Brain Res; 2001 Feb; 890(2):347-50. PubMed ID: 11164803
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Schmidt N; Ferger B
Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
Morgan WW; Nelson JF
Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of riluzole in MPTP-treated mice.
Araki T; Kumagai T; Tanaka K; Matsubara M; Kato H; Itoyama Y; Imai Y
Brain Res; 2001 Nov; 918(1-2):176-81. PubMed ID: 11684056
[TBL] [Abstract][Full Text] [Related]
6. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin.
Parain K; Hapdey C; Rousselet E; Marchand V; Dumery B; Hirsch EC
Brain Res; 2003 Sep; 984(1-2):224-32. PubMed ID: 12932857
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
Anderson DW; Neavin T; Smith JA; Schneider JS
Brain Res; 2001 Jun; 905(1-2):44-53. PubMed ID: 11423078
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage.
Quik M; Campos C; Parameswaran N; Langston JW; McIntosh JM; Yeluashvili M
J Mol Neurosci; 2010 Jan; 40(1-2):105-13. PubMed ID: 19685015
[TBL] [Abstract][Full Text] [Related]
10. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Teismann P; Ferger B
Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
[TBL] [Abstract][Full Text] [Related]
12. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
14. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action.
Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K
Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511
[TBL] [Abstract][Full Text] [Related]
15. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
16. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
17. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
18. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
Quik M; Parameswaran N; McCallum SE; Bordia T; Bao S; McCormack A; Kim A; Tyndale RF; Langston JW; Di Monte DA
J Neurochem; 2006 Sep; 98(6):1866-75. PubMed ID: 16882311
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.
Scheller D; Stichel-Gunkel C; Lübbert H; Porras G; Ravenscroft P; Hill M; Bezard E
Neurosci Lett; 2008 Feb; 432(1):30-4. PubMed ID: 18162314
[TBL] [Abstract][Full Text] [Related]
20. Minocycline enhances MPTP toxicity to dopaminergic neurons.
Yang L; Sugama S; Chirichigno JW; Gregorio J; Lorenzl S; Shin DH; Browne SE; Shimizu Y; Joh TH; Beal MF; Albers DS
J Neurosci Res; 2003 Oct; 74(2):278-85. PubMed ID: 14515357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
